UIM
EW icon

USS Investment Management’s Edwards Lifesciences EW Stock Holding History

USS Investment Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.6M Buy
139,422
+12,495
+10% +$1.05M 0.05% 256
2026
Q1 		$10.2M Buy
126,927
+9,504
+8% +$784K 0.04% 231
2025
Q4 		$10M Buy
117,423
+3,374
+3% +$277K 0.05% 226
2025
Q3 		$8.87M Sell
114,049
-543
-0.5% -$42.4K 0.04% 243
2025
Q2 		$8.96M Sell
114,592
-5,463
-5% -$407K 0.05% 225
2025
Q1 		$8.7M Buy
120,055
+1,884
+2% +$135K 0.06% 221
2024
Q4 		$8.75M Sell
118,171
-12,911
-10% -$904K 0.06% 246
2024
Q3 		$8.65M Sell
131,082
-7,833
-6% -$569K 0.06% 271
2024
Q2 		$12.8M Buy
138,915
+3,961
+3% +$351K 0.1% 163
2024
Q1 		$12.9M Buy
134,954
+16,360
+14% +$1.37M 0.11% 156
2023
Q4 		$9.05M Sell
118,594
-12,000
-9% -$835K 0.08% 205
2023
Q3 		$9.05M Buy
130,594
+2,061
+2% +$166K 0.1% 197
2023
Q2 		$12.1M Buy
+128,533
New +$11.2M 0.14% 148
2023
Q1 		– Sell
-115,997
Closed -$8.65M – 583
2022
Q4 		$8.65M Buy
115,997
+1,542
+1% +$119K 0.12% 186
2022
Q3 		$9.47M Sell
114,455
-38,984
-25% -$3.75M 0.14% 153
2022
Q2 		$14.6M Sell
153,439
-7,433
-5% -$769K 0.15% 148
2022
Q1 		$18.9M Buy
160,872
+10,947
+7% +$1.23M 0.16% 137
2021
Q4 		$19.4M Hold
149,925
– – 0.15% 139
2021
Q3 		$17M Buy
149,925
+98,907
+194% +$11.3M 0.14% 147
2021
Q2 		$5.29M Buy
+51,018
New +$4.81M 0.04% 251
2021
Q1 		– Sell
-51,018
Closed -$4.66M – 617
2020
Q4 		$4.66M Hold
51,018
– – 0.04% 238
2020
Q3 		$4.07M Buy
51,018
+1,958
+4% +$153K 0.04% 245
2020
Q2 		$3.39M Buy
+49,060
New +$3.49M 0.04% 260

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

USS Investment Management's EW Position: Q2 2026 in Review

USS Investment Management increased its Edwards Lifesciences (EW) stake by 9.8% in Q2 2026, buying an estimated $1.05M and bringing the position to 139,422 shares worth $12.6M. The position accounts for 0.05% of the portfolio, ranked #256.

USS Investment Management first reported a position in EW in Q2 2020 and has held it in 23 quarters since. The position peaked at $19.4M in Q4 2021. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • USS Investment Management held 139,422 shares of Edwards Lifesciences worth $12.6M as of Q2 2026.
  • USS Investment Management bought 12,495 Edwards Lifesciences shares in Q2 2026, an estimated $1.05M.
  • Edwards Lifesciences made up 0.05% of USS Investment Management's portfolio in Q2 2026, its #256 holding.
  • USS Investment Management first reported a position in Edwards Lifesciences in Q2 2020 and has held it in 23 quarters since.
  • USS Investment Management's Edwards Lifesciences position peaked at $19.4M in Q4 2021.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on USS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.